C[C@@H]1[C@H]2CCCC[C@H]2CN(C(=O)OC(C)(C)C)[C@@H]1c1cn(Cc2ccccc2)c2ccc(F)cc12
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?